skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hello 5i Team,
Could you please tell me the names of the companies that are developing a vaccine against Covid 19. Is there an ETF that tracks them?
Thanks,
Antoine
Read Answer Asked by Antoine on June 30, 2020
Q: ICad was added to the russel 2000 today yet dropped nearly 5%. Aren’t new additions to an index supposed to trigger a buy?
The company has been on a downtrend over last month. Any news to account for this? Do you still like? I understand it is very high risk.
Read Answer Asked by Karim on June 30, 2020
Q: I've held Facebook for 3 years and it has been a rollercoaster. It's a company that everyone loves to hate, and I am thinking of taking my profits and investing elsewhere. What would be a replacement stock in a similar area?
Read Answer Asked by Dennis on June 29, 2020
Q: I hold these 2 US stocks in a well diversified CAN/US portfolio. They have not performed as well as many of their peers and I am wondering if they are "best of breed" and worth holding or if there are better opportunities for growth elsewhere. Could you please comment on the future prospects of these 2 stocks and if its best to keep them or redeploy the funds elsewhere. If redeploy, what would you recommend as replacements in the US, sector allocation aside with a focus on growth
Read Answer Asked by Scott on June 26, 2020
Q: Do you have a number as to what the vaccine revenue might be for COVID 19 ?
It looks like perhaps 50 or more will be splitting the pie, yet a lot of money for all I think.
I am tracking NVAX, SRNE, MRNA.
All are up astronomically, but perhaps will double
Or more from here. Do you guys own any ?
Is there an ETF that holds these vaccine company’s?
Would you buy any, if so which one or one’s ?
I see SRNE is up 26% in the first 8 minutes this morning.
Thanks
Read Answer Asked by Luc on June 25, 2020
Q: This name had a nice pop after the favourable (almost glowing) Andrew Left/Citron research report. However, I see that there has been a lot of insider selling, which always makes me nervous and today I read that they are laying off a large percent of their workforce which is not exactly a glowing sign of success. What do you think about this company as a "stay at home" type of stock play? I do note your previous comments wherein you say that it was okay. Thank you.
Read Answer Asked by Jason on June 25, 2020